Cofoe Medical Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	1,422	1,279	1,569	1,450	1,989
Trading Asset Securities	1,017	1,357	851.3	1,243	1,537
Cash & Short-Term Investments	2,439	2,636	2,421	2,693	3,527
Cash Growth	-7.50%	8.90%	-10.12%	-23.63%	533.03%
Accounts Receivable	444.79	401.84	486	617.22	362.02
Other Receivables	61.37	47.52	30.63	46.15	32.42
Receivables	506.15	449.36	516.63	663.37	394.44
Inventory	675.5	659.58	634.72	529.36	480.75
Other Current Assets	215.14	180.45	258.66	314.63	117.11
Total Current Assets	3,835	3,925	3,831	4,201	4,519
Property, Plant & Equipment	1,750	1,637	1,696	1,598	879.7
Long-Term Investments	237.34	61.43	64.93	5.26	5.28
Goodwill	368.91	364.34	242.41	230.5	48.59
Other Intangible Assets	278.13	235.93	240.55	248.25	202.27
Long-Term Accounts Receivable	4.93	-	-	-	-
Long-Term Deferred Tax Assets	40.53	44.97	34.72	31.42	12.61
Long-Term Deferred Charges	63.51	52.8	50.92	60.32	47.75
Other Long-Term Assets	49.94	100.23	84.11	35.95	92.07
Total Assets	6,629	6,423	6,244	6,411	5,807
Accounts Payable	639.05	467.65	482.97	634.89	448.1
Accrued Expenses	118.1	95.89	92.09	144.45	58.84
Short-Term Debt	574.75	548.61	402.43	282.74	83.07
Current Portion of Long-Term Debt	125.08	114.01	12	13.81	10
Current Portion of Leases	58.31	54.12	55.01	51.69	41.89
Current Income Taxes Payable	3.9	17.8	3.76	28.47	23.31
Current Unearned Revenue	29.31	2.13	16.84	8.98	10
Other Current Liabilities	40.27	61.51	21.31	22.56	7.38
Total Current Liabilities	1,589	1,362	1,086	1,188	682.58
Long-Term Debt	-	125.17	94.1	30.03	5
Long-Term Leases	68.04	61.48	77.24	84.55	93.19
Long-Term Unearned Revenue	58.59	55.7	55.62	51.7	56.84
Pension & Post-Retirement Benefits	2.88	-	-	-	-
Long-Term Deferred Tax Liabilities	7.75	15.03	15.7	16.68	4.36
Other Long-Term Liabilities	-	1.21	6.94	7.41	-
Total Liabilities	1,726	1,620	1,336	1,378	841.97
Common Stock	208.9	209.09	209.24	208.49	160
Additional Paid-In Capital	3,926	3,931	3,933	3,913	3,917
Retained Earnings	874.29	868.67	923.4	914.88	869.8
Treasury Stock	-140.47	-212.12	-166.93	-15.74	-
Comprehensive Income & Other	-1.55	-	-	-	-
Total Common Equity	4,867	4,797	4,899	5,020	4,947
Minority Interest	36.03	5.75	9	12.57	17.94
Shareholders' Equity	4,903	4,802	4,908	5,033	4,965
Total Liabilities & Equity	6,629	6,423	6,244	6,411	5,807
Total Debt	826.18	903.4	640.77	462.82	233.15
Net Cash (Debt)	1,612	1,733	1,780	2,231	3,293
Net Cash Growth	-6.95%	-2.65%	-20.20%	-32.27%	1133.06%
Net Cash Per Share	7.85	8.42	8.69	10.70	20.00
Filing Date Shares Outstanding	203.2	203.39	203.7	203.94	208
Total Common Shares Outstanding	203.2	203.39	205.04	203.94	208
Working Capital	2,247	2,564	2,744	3,013	3,836
Book Value Per Share	23.95	23.58	23.89	24.62	23.78
Tangible Book Value	4,220	4,196	4,416	4,542	4,696
Tangible Book Value Per Share	20.77	20.63	21.54	22.27	22.58
Buildings	1,298	1,232	1,248	1,107	71.62
Machinery	520.6	479.08	407.64	259.17	193.3
Construction In Progress	138.63	50.13	49.33	171.39	508.49

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.